search
Back to results

Development of Imaging Biomarkers for Voice After Pediatric Airway Reconstruction

Primary Purpose

Voice Disorders

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Microlaryngoscopy
Voice Evaluation
Airway Reconstruction
Sponsored by
Children's Hospital Medical Center, Cincinnati
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Voice Disorders focused on measuring Voice, Biomarker, Airway Reconstruction

Eligibility Criteria

3 Years - 30 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Study Patients

Inclusion Criteria:

  1. Ages of 3-30 years,
  2. No prior airway surgery
  3. Able to undergo the evaluation protocol

Exclusion Criteria:

1.) Patients who have undergone any prior airway reconstruction and/or have a disability that precludes them from completing the evaluation

Control Patients

Inclusion Criteria:

  1. Age of 3-30 years
  2. No prior history of intubation injury or airway/laryngeal surgery
  3. Normal hearing
  4. Normal voice assessment performed by a certified speech-language pathologist 5.) Undergoing a non-airway surgical procedure such as adenoidectomy, tonsillectomy, ear tubes, and neck mass removal.

Exclusion Criteria:

  1. Has had airway or laryngeal surgery
  2. History of a voice or hearing disorder
  3. History of neonatal intubation over 14 days
  4. Have a disability that precludes them from completing the evaluation

Sites / Locations

  • CCHMC

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Study: Airway Reconstruction Patients

Control: Normal Airway Patients

Arm Description

These participants have significant airway abnormalities that require invasive surgery, such as Laryngotracheoplasty, to rectify, and whose voice quality may suffer as a result of the surgery. The goal of this study is to improve voice outcomes of these patients, and their clinical data will be collected.

These participants have normal airways and voice who will undergo a microlaryngoscopy and voice evaluation, the data from which will be compared to study patients.

Outcomes

Primary Outcome Measures

Identification of Patient's Vibratory Source
Vibratory source will be rated by having HSV imaging samples subjected to an automatic temporal segmentation, which will extract the HSV segment of interest. The extracted temporal segment (i.e. token) is subjected to an automatic image segmentation based on the oscillating edges of the anatomic structures using kymographic paired active contours. The image segmentation will be aided by an automatic spectral oscillation analysis similar to previously published methods. Three raters will be asked to interpret the image analysis results, which will be overlaid on the HSV image. To identify the patient's vibratory source, among the segmented vibratory areas, the raters will identify which vibratory structure(s)--glottis, false vocal folds, aryepiglottic folds, arytenoid against epiglottis, other supraglottal structures, or any combination of those--could be phonatory/which anatomic structure produced the vibration.

Secondary Outcome Measures

Tissue Health of Patient--Vocal Fold Vibration
Tissue health will be rated using a specialized Matlab graphic user interface (GUI). The rating protocol for preoperative and postoperative measurement will assess vibratory features on an ordinal scale, as follows: Vocal-fold vibration will be rated as: vibration with contact; vibration, no contact; no vibration, with contact; no vibration, no contact; can't identify vocal folds; or can't rate. The raters will then be asked to grade their overall rating confidence in their rating. Confidence will be graded on a 5-point scale as follows: 5-highly confident; 4-confident; 3-mostly confident; 2-somewhat confident; and 1- not confident or unable to rate.
Tissue Health of Patient--Scarring of Airway
Tissue health will be rated using a specialized Matlab graphic user interface (GUI). The rating protocol for preoperative and postoperative measurement will assess vibratory features on an ordinal scale, as follows:Scarring will be rated as: no scar; mild-left; mild-right; mild-bilateral; moderate-left; moderate- right; moderate- bilateral; severe-left; severe-right; severe- bilateral; or can't rate. For the visual rating of scarring, we will use the following definitions: mild scarring - present scar that has no effect or mildly reduces the mucosal wave; moderate scarring - reduced mucosal wave; severe scarring - mucosal wave not present. The raters will then be asked to grade their overall rating confidence in their rating. Confidence will be graded on a 5-point scale as follows: 5-highly confident; 4-confident; 3-mostly confident; 2-somewhat confident; and 1- not confident or unable to rate.
Maximum Adduction
The computation of the adduction and abduction will be based on automatic image segmentation using temporally-paired active contours followed by extraction of a glottal area width (GAW) signal. This measure will be calibrated to the units of mm based on the segmented airway size relative to the size of the calibration surgical instrument recorded on the intraoperative image. Maximum adduction will be computed from the GAW signal.
Maximum Abduction
The computation of the adduction and abduction will be based on automatic image segmentation using temporally-paired active contours followed by extraction of a glottal area width (GAW) signal. This measure will be calibrated to the units of mm based on the segmented airway size relative to the size of the calibration surgical instrument recorded on the intraoperative image. Maximum abduction will be computed from the GAW signal.
Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V)
Three certified speech-language pathologists with extensive experience in the assessment and treatment of pediatric voice disorders will perform all CAPE-V ratings. Each sample will contain the six CAPE-V sentences or modified sentences based on the ability of the child. Rating sheets will list only the participant's study number, age, and gender. Judges will independently listen to the samples (a maximum of three times per sample) in a quiet environment using headphones (the headphones will not have a separate volume control function. Averages of the three judges will be performed to obtain the Overall Severity rating. Twenty-five percent of the voice samples will be randomly selected to estimate intra-rater reliability. Inter-rater reliability will also be evaluated. If CAPE-V Overall Severity ratings differ greater than 20%, samples will be set aside and evaluated in a consensus of all three judges. This consensus will establish the final Overall Severity rating.
Pediatric Voice Handicap Index
Questionnaire designed to assess the impact on quality of life that the patient's voice problems pose. This is administered during each voice evaluation to track changes. Voice handicapping/voice-related quality of life will be evaluated using the Pediatric Voice Handicap Index (pVHI). The pVHI is a handicapping index that was modified from the original Adult Voice Handicap Index into a parental proxy form. The pVHI is a self-rating of voice handicapping based on a summed score (0-92). This system has three domains: 1) functional, 2) physical, and 3) emotional.

Full Information

First Posted
December 15, 2016
Last Updated
February 4, 2021
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
Triological Society
search

1. Study Identification

Unique Protocol Identification Number
NCT03076931
Brief Title
Development of Imaging Biomarkers for Voice After Pediatric Airway Reconstruction
Official Title
Development of Imaging Biomarkers for Voice After Pediatric Airway Reconstruction
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Terminated
Why Stopped
0 subjects completed all study visits. Due to noncompliance and recruitment difficulties study was terminated.
Study Start Date
August 1, 2016 (Actual)
Primary Completion Date
October 15, 2019 (Actual)
Study Completion Date
October 15, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
Triological Society

4. Oversight

5. Study Description

Brief Summary
Objective: The purpose of this proposal is to use High Speed Videoendoscopy (HSV) to develop and test an imaging biomarker to support diagnosis and predict vibratory outcome after airway reconstruction. Our protocol will involve eliciting and recording the following five behaviors: (1) hard throat clear; (2) cough; (3) laugh; (4) short multiple phonations; and (5) sustained phonation. These HSV recordings will be used to develop the biomarkers. Study Design: A prospective cohort study of 60 patients, 36 who will undergo airway reconstruction and 24 age matched controls. Setting: Center for Pediatric Voice Disorders, Department of Otolaryngology, Cincinnati Children's Hospital Medical Center Methods: Subjects will undergo a full voice evaluation, including an HSV evaluation protocol, at the main study site prior to airway reconstruction, 6 months post and 1 year post surgery. Voice evaluation will include aerodynamic, acoustic, and perceptual voice assessments, a pediatric voice handicap index questionnaire, videostroboscopy, and HSV. The airway evaluation will include airway sizing and calibration.
Detailed Description
Fifty percent of the children who undergo airway reconstruction for subglottic stenosis (narrowing of the airway below the vocal folds) develop a voice disorder. Voice disorders lead to psychosocial problems that affect many of these children over their lifetime, specifically their career choices and their long-term quality of life. Our current understanding of voice problems following surgical airway reconstruction is limited. There is a lack of research to understand the alterations of the phonatory mechanisms due to the underlying initial condition (stenosis) and the surgical airway reconstruction performed. The purpose of this proposal is to develop and test imaging biomarkers to support diagnosis and surgical decision-making leading to improved voice outcome. The overarching goal of this work is to establish a foundation upon which surgical practice could be enhanced to improve voice outcome while still achieving optimal airway results. Specifically, the project will use: a prospective pre- and post-surgery cohort design to develop an imaging biomarker of "vibratory potential" for predicting the vibratory outcome after airway reconstruction. Quantitative image processing methodology will be used for the development and validation of the new imaging biomarkers, based on high-speed videoendoscopy. This research project will address a substantial gap of knowledge in pediatric voice and airway surgery, and has the potential to significantly improve the quality of life of these patients who have some of the most severe and difficult to manage voice disorders. The results could be translated to adult patient populations and other voice disorders (e.g. development of disease-specific imaging biomarkers).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Voice Disorders
Keywords
Voice, Biomarker, Airway Reconstruction

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
2 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Study: Airway Reconstruction Patients
Arm Type
Experimental
Arm Description
These participants have significant airway abnormalities that require invasive surgery, such as Laryngotracheoplasty, to rectify, and whose voice quality may suffer as a result of the surgery. The goal of this study is to improve voice outcomes of these patients, and their clinical data will be collected.
Arm Title
Control: Normal Airway Patients
Arm Type
Experimental
Arm Description
These participants have normal airways and voice who will undergo a microlaryngoscopy and voice evaluation, the data from which will be compared to study patients.
Intervention Type
Procedure
Intervention Name(s)
Microlaryngoscopy
Other Intervention Name(s)
MLB
Intervention Description
Standard clinical procedure, used to perform airway sizing and vocal fold calibration. Controls receive one as a research procedure, while study patients receive one as part of standard of care.
Intervention Type
Procedure
Intervention Name(s)
Voice Evaluation
Intervention Description
Standard clinical procedure that includes aerodynamic, acoustic, and perceptual voice assessments, a pediatric voice handicap index questionnaire, videostroboscopy, and high-speed videoendoscopy. Controls will receive one as a research procedure, while study patients will receive three, one before their airway reconstruction, and two more in the year afterward, as part of standard of care.
Intervention Type
Procedure
Intervention Name(s)
Airway Reconstruction
Intervention Description
This includes many types of invasive surgical procedures such as Laryngotracheoplasty to repair a patient's compromised airway. Only study patients will be receiving one, and it will be as part of standard of care unrelated to this study, but the data from surgery and outcomes being pertinent to the study.
Primary Outcome Measure Information:
Title
Identification of Patient's Vibratory Source
Description
Vibratory source will be rated by having HSV imaging samples subjected to an automatic temporal segmentation, which will extract the HSV segment of interest. The extracted temporal segment (i.e. token) is subjected to an automatic image segmentation based on the oscillating edges of the anatomic structures using kymographic paired active contours. The image segmentation will be aided by an automatic spectral oscillation analysis similar to previously published methods. Three raters will be asked to interpret the image analysis results, which will be overlaid on the HSV image. To identify the patient's vibratory source, among the segmented vibratory areas, the raters will identify which vibratory structure(s)--glottis, false vocal folds, aryepiglottic folds, arytenoid against epiglottis, other supraglottal structures, or any combination of those--could be phonatory/which anatomic structure produced the vibration.
Time Frame
Up to One Year
Secondary Outcome Measure Information:
Title
Tissue Health of Patient--Vocal Fold Vibration
Description
Tissue health will be rated using a specialized Matlab graphic user interface (GUI). The rating protocol for preoperative and postoperative measurement will assess vibratory features on an ordinal scale, as follows: Vocal-fold vibration will be rated as: vibration with contact; vibration, no contact; no vibration, with contact; no vibration, no contact; can't identify vocal folds; or can't rate. The raters will then be asked to grade their overall rating confidence in their rating. Confidence will be graded on a 5-point scale as follows: 5-highly confident; 4-confident; 3-mostly confident; 2-somewhat confident; and 1- not confident or unable to rate.
Time Frame
Up to One Year
Title
Tissue Health of Patient--Scarring of Airway
Description
Tissue health will be rated using a specialized Matlab graphic user interface (GUI). The rating protocol for preoperative and postoperative measurement will assess vibratory features on an ordinal scale, as follows:Scarring will be rated as: no scar; mild-left; mild-right; mild-bilateral; moderate-left; moderate- right; moderate- bilateral; severe-left; severe-right; severe- bilateral; or can't rate. For the visual rating of scarring, we will use the following definitions: mild scarring - present scar that has no effect or mildly reduces the mucosal wave; moderate scarring - reduced mucosal wave; severe scarring - mucosal wave not present. The raters will then be asked to grade their overall rating confidence in their rating. Confidence will be graded on a 5-point scale as follows: 5-highly confident; 4-confident; 3-mostly confident; 2-somewhat confident; and 1- not confident or unable to rate.
Time Frame
Up to One Year
Title
Maximum Adduction
Description
The computation of the adduction and abduction will be based on automatic image segmentation using temporally-paired active contours followed by extraction of a glottal area width (GAW) signal. This measure will be calibrated to the units of mm based on the segmented airway size relative to the size of the calibration surgical instrument recorded on the intraoperative image. Maximum adduction will be computed from the GAW signal.
Time Frame
Up to One Year
Title
Maximum Abduction
Description
The computation of the adduction and abduction will be based on automatic image segmentation using temporally-paired active contours followed by extraction of a glottal area width (GAW) signal. This measure will be calibrated to the units of mm based on the segmented airway size relative to the size of the calibration surgical instrument recorded on the intraoperative image. Maximum abduction will be computed from the GAW signal.
Time Frame
Up to One Year
Title
Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V)
Description
Three certified speech-language pathologists with extensive experience in the assessment and treatment of pediatric voice disorders will perform all CAPE-V ratings. Each sample will contain the six CAPE-V sentences or modified sentences based on the ability of the child. Rating sheets will list only the participant's study number, age, and gender. Judges will independently listen to the samples (a maximum of three times per sample) in a quiet environment using headphones (the headphones will not have a separate volume control function. Averages of the three judges will be performed to obtain the Overall Severity rating. Twenty-five percent of the voice samples will be randomly selected to estimate intra-rater reliability. Inter-rater reliability will also be evaluated. If CAPE-V Overall Severity ratings differ greater than 20%, samples will be set aside and evaluated in a consensus of all three judges. This consensus will establish the final Overall Severity rating.
Time Frame
Up to One Year
Title
Pediatric Voice Handicap Index
Description
Questionnaire designed to assess the impact on quality of life that the patient's voice problems pose. This is administered during each voice evaluation to track changes. Voice handicapping/voice-related quality of life will be evaluated using the Pediatric Voice Handicap Index (pVHI). The pVHI is a handicapping index that was modified from the original Adult Voice Handicap Index into a parental proxy form. The pVHI is a self-rating of voice handicapping based on a summed score (0-92). This system has three domains: 1) functional, 2) physical, and 3) emotional.
Time Frame
Up to One Year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Study Patients Inclusion Criteria: Ages of 3-30 years, No prior airway surgery Able to undergo the evaluation protocol Exclusion Criteria: 1.) Patients who have undergone any prior airway reconstruction and/or have a disability that precludes them from completing the evaluation Control Patients Inclusion Criteria: Age of 3-30 years No prior history of intubation injury or airway/laryngeal surgery Normal hearing Normal voice assessment performed by a certified speech-language pathologist 5.) Undergoing a non-airway surgical procedure such as adenoidectomy, tonsillectomy, ear tubes, and neck mass removal. Exclusion Criteria: Has had airway or laryngeal surgery History of a voice or hearing disorder History of neonatal intubation over 14 days Have a disability that precludes them from completing the evaluation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alessandro de Alarcon, MD
Organizational Affiliation
CCHMC
Official's Role
Principal Investigator
Facility Information:
Facility Name
CCHMC
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45229
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Development of Imaging Biomarkers for Voice After Pediatric Airway Reconstruction

We'll reach out to this number within 24 hrs